ARCHIVES

ASCO Annual Meeting: PARP Inhibitors Show Promise Against Breast Cancer In Small Phase II Studies

This article is from The Cancer Letter archive.

Vol. 35 No. 22 | June 5, 2009

Download PDF Visit The Full Archive

Related Articles

National Cancer Policy Board calls for public-private partnership for R&D in pediatric cancer drugs.

April 22, 2005

NINDS Awards Grants For Brain Tumor Centers

December 11, 1992

FDA News: FDA Approves Reagent System for Graft-Versus-Host Disease

January 24, 2014

Outcomes Research Pioneer Jane Carrie Weeks Dies at 61

September 13, 2013

FDA Approves Treatment For Late-Stage Cervical Cancer

June 30, 2006

Q & A With Shannon Brownlee: Task Force Independence at Stake In Debate over PSA Screening

October 6, 2011